Catastrophic antiphospholipid syndrome: Task force report summary

Lupus

Volumn 23, Issue 12, 2014, Pages 1283-1285

  Cervera, R ^a   Rodriguez Pinto I ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

anticardiolipin antibodies; antiphospholipid antibodies; Antiphospholipid syndrome; lupus anticoagulant

Indexed keywords

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EPIDEMIOLOGY; HUMAN; KNOWLEDGE; PATHOGENESIS; PATIENT RISK; PLASMAPHERESIS; RISK ASSESSMENT; RISK FACTOR; ADVISORY COMMITTEE; CLASSIFICATION;

ADVISORY COMMITTEES; ANTIPHOSPHOLIPID SYNDROME; HUMANS;

EID: 84908674531     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314540764     Document Type: Conference Paper

References (13)

1. Cervera R, Rodríguez-Pintó I, Colafrancesco S, et al. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. Autoimmun Rev. 2014 ; 13: 699-707
2. Kitchens CS. Thrombotic storm: When thrombosis begets thrombosis. Am J Med. 1998 ; 104: 381-385
3. Cervera R, Bucciarelli S, Plasín MA, et al. Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the "CAPS Registry". J Autoimmun. 2009 ; 32: 240-245
4. Espinosa G, Bucciarelli S, Cervera R, Gómez-Puerta JA, Font J. Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome. Autoimmun Rev. 2006 ; 6: 68-71
5. Agmon-Levin N, Rosário C, Katz B-SP, et al. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS). Lupus. 2013 ; 22: 1327-1335
6. Cervera R, Tektonidou MG, Espinosa G, et al. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): Catastrophic APS, APS nephropathy and heart valve lesions. Lupus. 2011 ; 20: 165-173
7. De Runz A, Zuily S, Gosset J, Wahl D, Simon E. Particular catastrophic antiphospholipid syndrome, on the sole surgical site after breast reduction. J Plast Reconstr Aesthet Surg. 2013 ; 66: e321 - e324
8. Katikireddi VS, Kandiah DA. Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy. Intern Med J. 2012 ; 42: 585-591
9. Amital H, Levy Y, Davidson C, et al. Catastrophic antiphospholipid syndrome: Remission following leg amputation in 2 cases. Semin Arthritis Rheum. 2001 ; 31: 127-132
10. Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. 2013 ; 368: 2113-2124
11. Cervera R. Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome. Curr Rheumatol Rep. 2010 ; 12: 70-76
12. Bucciarelli S, Espinosa G, Cervera R, et al. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 2006 ; 54: 2568-2576
13. Asherson RA, Cervera R. The catastrophic antiphospholipid syndrome: A review of pathogenesis, clinical features and treatment. Isr Med Assoc J. 2000 ; 2: 268-273